Interestingly, SRCIN1 hypermethylation did not occur in other cancer types within the Taiwanese and TCGA datasets, confirming the usefulness of SRCIN1 as a biomarker specifically for breast cancer patients. The gene discussed is SRCIN1; the disease is breast cancer.